Cardinal Health, Inc.
Location
Ohio
Founded
1979-02-28
Website
Risk Signals
3280 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medical, Dental, and Hospital Equipment and Supplies, Drugs, Drug Proprietaries, and Druggists' Sundries, Management Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Cardinal Health, Inc.
Live alerts from global media, monitored by Business Radar
2025-05-01 (forecastock.tw)
Cardina Health's earnings per share forecast for fiscal 2025 has been raised to $8.05-8.15, driven by strong drug growth and mergers and acquisitions! |
Cardina Health CEO announced its outstanding performance in the third quarter, updating its earnings per share forecast for fiscal year 2025, showing the company's stable business model and growth potential.
Read more
2025-05-01 (nasdaq.com)
CAH Q3 Earnings Beat Estimates, '25 EPS View Raised, Stock Gains |
Cardinal Health's third-quarter fiscal 2025 results benefit from solid Medical and Other segment revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.
Read more
2025-05-01 (investing.com)
Earnings call transcript: Cardinal Health Q1 2025 beats EPS expectations, stock rises By Investing.com
Earnings call transcript: Cardinal Health Q1 2025 beats EPS expectations, stock rises
Read more
2025-02-15 (etfdailynews.com)
Apollon Wealth Management LLC Decreases Position in Cardinal Health, Inc. (NYSE:CAH) -
Read Apollon Wealth Management LLC Decreases Position in Cardinal Health, Inc. (NYSE:CAH) at ETF Daily News
Read more
2025-01-31 (finanzen.ch)
Cardinal Health presented a quarterly result | 01/31/25 |
Cardinal Health reported the figures for the recent quarter on January 30, 2025 at the quarterly financial conference. The profit per share was ...
Read more
2025-01-31 (finimize.com)
Cardinal Health Raises Profit Forecast As Drug Demand Grows -
Boosted by specialty medicines, Cardinal Health exceeds profit expectations with strategic diversification
Read more
2025-01-30 (chaindrugreview.com)
Cardinal Health reports Q2 fiscal year 2025 results
DUBLIN, Ohio – Cardinal Health has reported second quarter fiscal year 2025 revenues of $55.3 billion, a decrease of 4% from the second quarter of fiscal year 2024. Second quarter revenue increased 16% excluding the impact of the previously communicated large customer contract expiration.
Read more
2025-01-30 (drugstorenews.com)
Cardinal Health reports Q2 results, raises fiscal year 2025 outlook |
Cardinal Health's pharmaceutical and specialty solutions segment profit increased 7% to $531 million in the second quarter.
Read more
2025-01-17 (marketbeat.com)
Occidental Asset Management LLC Has $4.01 Million Stock Position in Cardinal Health, Inc. (NYSE:CAH)
Occidental Asset Management LLC grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 10.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 33,873 shares of the company's stock after buying an additional 3
Read more
2025-01-14 (investing.com)
Cardinal Health Raises Annual Profit Forecast, Driven by Pharmaceutical Segment By .com
Cardinal Health Raises Annual Profit Forecast, Boosted by Pharmaceuticals Segment
Read more
2025-01-14 (tipranks.com)
Cardinal Health Raises 2025 Earnings Forecast Expectations - TipRanks.com
Cardinal Health ( ($CAH) ) has issued an announcement. Cardinal Health updated its non-GAAP diluted earnings per share expectations for fiscal year 2025, now antici...
Read more
2025-01-07 (manilatimes.net)
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results |
Achieved record fourth quarter and full-year 2024 sepsis product revenues
Read more